Oncolytics Biotech
(OTC:ONCWF)
0.0046
00
At close: May 10

Oncolytics Biotech (OTC:ONCWF), Quotes and News Summary

Oncolytics Biotech (OTC: ONCWF)

There is no Press for this Ticker
Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The company's product pipeline includes Bavencio, Keytruda, Retifanlimab, and Tecentriq.

Oncolytics Biotech Questions & Answers

Q
How do I buy Oncolytics Biotech (ONCWF) stock?
A

You can purchase shares of Oncolytics Biotech (OTC: ONCWF) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Oncolytics Biotech's (ONCWF) competitors?
A

There are no as such competitors for Oncolytics Biotech.

Q
What is the target price for Oncolytics Biotech (ONCWF) stock?
A

There is no analysis for Oncolytics Biotech

Q
Current Stock Price for Oncolytics Biotech (ONCWF)?
A

The stock price for Oncolytics Biotech (OTC: ONCWF) is $0.0046 last updated May 10, 2022, 1:30 PM UTC.

Q
Does Oncolytics Biotech (ONCWF) pay a dividend?
A

There are no upcoming dividends for Oncolytics Biotech.

Q
When is Oncolytics Biotech (OTC:ONCWF) reporting earnings?
A

Oncolytics Biotech does not have any upcoming earnings scheduled.

Q
Is Oncolytics Biotech (ONCWF) going to split?
A

There is no upcoming split for Oncolytics Biotech.

Q
What sector and industry does Oncolytics Biotech (ONCWF) operate in?
A

Oncolytics Biotech is in the Healthcare sector and Biotechnology industry. They are listed on the OTC.